cCeLL - In vivo
K-Number: K260315 · 2026-10-16
Advertisement
Device Summary
Frequently Asked Questions
What is the cCeLL - In vivo?
cCeLL - In vivo is a medical device that received FDA 510(k) clearance on 2026-10-16. The listed applicant is VPIX Medical, Inc.. The 510(k) number is K260315.
When did cCeLL - In vivo receive FDA 510(k) clearance?
cCeLL - In vivo received FDA 510(k) clearance on 2026-10-16, under 510(k) number K260315.
Who is the listed applicant for cCeLL - In vivo?
The FDA 510(k) record lists VPIX Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for cCeLL - In vivo?
The FDA product code for cCeLL - In vivo is GWG.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing VPIX Medical, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GWG)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement